Nasal delivery system for peptide drugs: Market trend and technology development

Drug Delivery System

Volumn 21, Issue 4, 2006, Pages 426-434

  Morita, Takahiro ^a   Yamahara, Hiroshi ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

mucolytic agent; mucus barrier; nasal administration; non water absorbable carrier; peptide drugs; powdery formulation

Indexed keywords

EID: 74149088082     PISSN: 09135006     EISSN: 18812732     Source Type: Journal    
DOI: 10.2745/dds.21.426     Document Type: Article

References (23)

1. Dahl R, Mygind N : Anatomy, physiology and function of the nasal cavities in health and disease. Adv Drug Delivery Rev 29 : 3-12, 1998.
2. Merkus FW, Verhoef JC, Schipper NG, Marttin E : Nasal mucociliary clearance as a factor in nasal drug delivery. Adv Drug Delivery Rev 29 : 13-38, 1998.
3. Johnson PH, Quay SC : Advances in nasal drug delivery through tight junction technology. Expert Opin Drug Delivery 2 : 281-298, 2005.
4. Minn A, Leclerc S, Heydel JM, Minn AL, Denizcot C et al. : Drug transport into the mammalian brain : the nasal pathway and its specific metabolic barrier. J Drug Target 10 : 285-296, 2002.
5. Morita T, Yamahara H : Peptides and proteins-nasal absorption. Encyclopedia of pharmaceutical technology, 2nd Edition. (eds. Swarbrick J, Boylan JC), Marcel Dekker, New York, 2004, 1-11.
6. Romeo VD, deMeireles J, Sileno AP, Pimplaskar HK, Behl CR : Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Delivery Rev 29 : 89-116, 1998.
7. Illum L : Nasal drug delivery-possibilities, problems and solutions. J Control Release 87 : 187-198, 2003.
8. Illum L : Nasal drug delivery : new developments and strategies. Drug Discovery Today 7 : 1184-1189, 2002.
9. Lee VH : Enzymatic barriers to peptide and protein absorption. Crit Rev Ther Drug Carrier System 5 : 69-97, 1998.
10. Ugwoke MI, Verbeke N, Kinget R : The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 53 : 3-22, 2001.
11. Kompella UB, Lee VH : Delivery systems for penetration enhancement of peptide and protein drugs : design considerations. Adv Drug Delivery Rev 46 : 211-245, 2001.
12. Davis SS, Illum L : Absorption enhancers for nasal drug delivery. Clin Pharmacokinet 42 : 1107-1128, 2003.
13. Ohtake K, Natsume H, Ueda H, Morimoto Y : Analysis of transient and reversible effects of poly-L-arginine on the in vivo nasal absorption of FITC-dextran in rats. J Control Release 82 : 263-275, 2002.
14. Chen SC, Eiting K, Cui K, Leonard AK, Morris D et al. : Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery. J Pharm Sci 95 : 1364-1371, 2006.
15. Sarkar MA : Drug metabolism in the nasal mucosa. Pharm Res 9 : 1-9, 1992.
16. Matsuyama T, Morita T, Horikiri Y, Yamahara H, Yoshino H : Enhancement of nasal absorption of large molecular weight compounds by combination of mucolytic agent and nonionic surfactant. J Control Release 110 : 347-352, 2006.
17. Ugwoke MI, Agu RU, Verbeke N, Kinget R : Nasal mucoadhesive drug delivery : Background, applications, trends and future perspectives. Adv Drug Delivery Rev 57 : 1640-1665, 2005.
18. Ishikawa F, Murano M, Hiraishi M, Yamaguchi T, Tamai I, Tsuji A : Insoluble powder formulation as an effective nasal drug delivery system. Pharm Res 19 : 1097-1104, 2002.
19. Ishikawa F, Katsura M, Tamai I, Tsuji A : Improved nasal bioavailability of elcatonin by insoluble powder formulation. Int J Pharm 224 : 105-114, 2001.
20. Matsuyama T, Morita T, Horikiri Y, Yamahara H, Yoshino H : Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine as a mucolytic agent. J Control Release, (submitted).
21. Matsuyama T, Morita T, Horikiri Y, Yamahara H, Yoshino H : Effect of filler on nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine. J Control Release, (in preparation).
22. Ugwoke MI, Agu RU, Vanbilloen H, Baetens J, Augustijns P et al. : Scintigraphic evaluation in rabbits of nasal drug delivery systems based on carbopol 971p and carboxymethylcellulose. J Control Release 68 : 207-214, 2000.
23. Newman SP, Pitcairn GR, Dalby RN : Drug delivery to the nasal cavity : in vitro and in vivo assessment. Crit Rev Ther Drug Carrier Syst 21 : 21-66, 2004.